1. | The current status of cardiovascular risk factors in Turkey Adnan Abacı doi: 10.5543/tkda.2011.abaci Pages 1 - 5 |
2. | Methods of risk estimation for cardiovascular disease Hakan Kültürsay doi: 10.5543/tkda.2011.kultursay Pages 6 - 13 |
3. | Treatment of dyslipidemia in primary prevention and rosuvastatin Fatih Sinan Ertaş doi: 10.5543/tkda.2011.ertas Pages 14 - 18 |
4. | Translation: [Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities] Pages 19 - 28 |
Copyright © 2024 Archives of the Turkish Society of Cardiology